Imaging of CDH17-positive gastric cancer xenografts with 64Cu-labeled anti-CDH17 IgG PET

被引:0
|
作者
Fujiwara, K. [1 ]
Koyama, K. [1 ]
Suga, K. [2 ]
Takahashi, M. [1 ]
Kusano-Arai, O. [3 ]
Mitsui, K. [3 ]
Akiba, H. [4 ]
Iwanari, H. [3 ]
Tsumoto, K. [4 ]
Hamakubo, T. [3 ]
Momose, T. [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Radiol, Tokyo, Japan
[2] SANKYO LABO SERV Co Ltd, Tokyo, Japan
[3] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Tokyo, Japan
[4] Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
P166
引用
收藏
页码:S420 / S420
页数:1
相关论文
共 50 条
  • [31] A Novel PET Imaging Using 64Cu-Labeled Monoclonal Antibody against Mesothelin Commonly Expressed on Cancer Cells
    Kobayashi, Kazuko
    Sasaki, Takanori
    Takenaka, Fumiaki
    Yakushiji, Hiromasa
    Fujii, Yoshihiro
    Kishi, Yoshiro
    Kita, Shoichi
    Shen, Lianhua
    Kumon, Hiromi
    Matsuura, Eiji
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [32] High-Resolution Animal PET Imaging of Prostate Cancer Xenografts with Three Different 64Cu-Labeled Antibodies against Native Cell-Adherent PSMA
    Alt, Karen
    Wiehr, Stefan
    Ehrlichmann, Walter
    Reischl, Gerald
    Wolf, Philipp
    Pichler, Bernd J.
    Esaesser-Beile, Ursula
    Buehler, Patrick
    PROSTATE, 2010, 70 (13): : 1413 - 1421
  • [33] PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII
    Nielsen, Carsten H.
    Jeppesen, Troels E.
    Kristensen, Lotte K.
    Jensen, Mette M.
    El Ali, Henrik H.
    Madsen, Jacob
    Wiinberg, Bo
    Petersen, Lars C.
    Kjaer, Andreas
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (07) : 1112 - 1119
  • [34] Preclinical Evaluation of Novel 64Cu-Labeled Gastrin-Releasing Peptide Receptor Bioconjugates for PET Imaging of Prostate Cancer
    Makris, George
    Shegani, Antonio
    Kankanamalage, Pavithra H. A.
    Kuchuk, Marina
    Bandari, Rajendra P.
    Smith, Charles J.
    Hennkens, Heather M.
    BIOCONJUGATE CHEMISTRY, 2021, 32 (07) : 1290 - 1297
  • [35] PET imaging of Hsp90 expression in pancreatic cancer using a new 64Cu-labeled dimeric Sansalvamide A decapeptide
    Wang, Xiaohui
    Zhang, Jun
    Wu, Hubing
    Li, Yumin
    Conti, Peter S.
    Chen, Kai
    AMINO ACIDS, 2018, 50 (07) : 897 - 907
  • [36] PET imaging of Hsp90 expression in pancreatic cancer using a new 64Cu-labeled dimeric Sansalvamide A derivative
    Wang, Xiaohui
    Zhang, Jun
    Wu, Hubing
    Li, Yumin
    Conti, Peter
    Chen, Kai
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [37] PET imaging of human T cells using a high specific activity 64Cu-labeled anti-CD3 antibody
    Lepin, Eric
    Torgov, Michael
    Satpayev, Daulet
    Beigarten, Charles
    Cabral, Edward
    Gudas, Jean
    Olafsen, Tove
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [38] PET imaging of Hsp90 expression in pancreatic cancer using a new 64Cu-labeled dimeric Sansalvamide A decapeptide
    Xiaohui Wang
    Jun Zhang
    Hubing Wu
    Yumin Li
    Peter S. Conti
    Kai Chen
    Amino Acids, 2018, 50 : 897 - 907
  • [39] Selective Tumor Cell Apoptosis and Tumor Regression in CDH17-Positive Colorectal Cancer Models using BI 905711, a Novel Liver-Sparing TRAILR2 Agonist
    Garcia-Martinez, Juan Manuel
    Wang, Shirley
    Weishaeupl, Cordula
    Wernitznig, Andreas
    Chetta, Paolo
    Pinto, Catarina
    Ho, Jason
    Dutcher, Darrin
    Gorman, Philip N.
    Kroe-Barrett, Rachel
    Rinnenthal, Joerg
    Giragossian, Craig
    Impagnatiello, Maria Antonietta
    Tirapu, Inigo
    Hilberg, Frank
    Kraut, Norbert
    Pearson, Mark
    Kuenkele, Klaus Peter
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (01) : 96 - 108
  • [40] Tumor and organ uptake of 64Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies
    Lee, Jae-Ho
    Kim, Heejung
    Yao, Zhengsheng
    Lee, Sung-Jin
    Szajek, Lawrence P.
    Grasso, Luigi
    Pastan, Ira
    Paik, Chang H.
    NUCLEAR MEDICINE AND BIOLOGY, 2015, 42 (11) : 880 - 886